Category In The News
An interview with Max Wallace, CEO of Accelerate Brain Cancer Cure.
Max Wallace, CEO of ABC², responds to the op-ed piece by Llewellyn Hinkes-Jones published this week in the New York Times.
ABC2-funded research in the news and a blog post by Al Musella, of the Musella Foundation, about Novocure's promising Optune trial results.
Accelerate Brain Cancer Cure funded Duke University's early work on the vaccine.
ABC2 CEO Max Wallace chaired the gathering of NCI experts and cancer advocates.
Principal Investigators, based in the state of Florida, are invited to apply. Proposal deadline: December 15, 2014.
Dr. Jim Olson and his scientific team will begin injecting brain cancer patients with the cancer detecting Tumor Paint made from the venom of deathstalker scorpions.
ABC2's Fall Associate Sierra Alef-Defoe explores the pediatric brain cancer research landscape in honor of her friend Sydney and in recognition of National Childhood Cancer Awareness Month.
A TV news interview with 5k founder Greg Schnoor about the upcoming event and his support for ABC2.
NCI Director Harold Varmus, ABC2 CEO Max Wallace and prominent cancer researchers exchanged ideas with leading pediatric cancer advocates.